Meihao Medical Group Co., Ltd (HKG:1947)
Hong Kong
· Delayed Price · Currency is HKD 0.360
0.00 (0.00%)
At close: Mar 10, 2026
Meihao Medical Group Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
| Revenue | 84.45 | 74.68 | 73.51 | 127.41 | 105.32 | 84.56 | Upgrade
|
| Revenue Growth (YoY) | 16.77% | 1.59% | -42.30% | 20.98% | 24.55% | 1.68% | Upgrade
|
| Cost of Revenue | 53.81 | 47.7 | 40.86 | 49.16 | 38.39 | 33.94 | Upgrade
|
| Gross Profit | 30.65 | 26.98 | 32.66 | 78.25 | 66.93 | 50.62 | Upgrade
|
| Selling, General & Admin | 56.09 | 59.53 | 43.6 | 35.71 | 22.6 | 25.18 | Upgrade
|
| Other Operating Expenses | - | - | - | - | - | 0.07 | Upgrade
|
| Operating Expenses | 56.1 | 59.54 | 43.6 | 35.69 | 22.29 | 25.3 | Upgrade
|
| Operating Income | -25.45 | -32.56 | -10.95 | 42.56 | 44.64 | 25.31 | Upgrade
|
| Interest Expense | -1.62 | -1.62 | -1.63 | -1.89 | -2.47 | -1.83 | Upgrade
|
| Interest & Investment Income | 3.7 | 3.7 | 4.97 | 1.65 | 1.21 | 0.45 | Upgrade
|
| Currency Exchange Gain (Loss) | 0.11 | 0.11 | 0.06 | - | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | -1.18 | 0.22 | 0.07 | -0.84 | 0.03 | -0.13 | Upgrade
|
| EBT Excluding Unusual Items | -24.43 | -30.15 | -7.48 | 41.49 | 43.41 | 23.8 | Upgrade
|
| Other Unusual Items | 0 | 0 | 0.32 | -1.28 | 0.26 | 0.39 | Upgrade
|
| Pretax Income | -24.43 | -30.15 | -7.16 | 40.2 | 43.67 | 24.19 | Upgrade
|
| Income Tax Expense | 2.99 | 2.48 | 6.45 | 11.63 | 11.49 | 9.21 | Upgrade
|
| Earnings From Continuing Operations | -27.42 | -32.62 | -13.61 | 28.57 | 32.18 | 14.98 | Upgrade
|
| Minority Interest in Earnings | 0.07 | 0.2 | 0.01 | -0.11 | -0.11 | -0.08 | Upgrade
|
| Net Income | -27.36 | -32.42 | -13.59 | 28.46 | 32.07 | 14.9 | Upgrade
|
| Net Income to Common | -27.36 | -32.42 | -13.59 | 28.46 | 32.07 | 14.9 | Upgrade
|
| Net Income Growth | - | - | - | -11.27% | 115.19% | -3.41% | Upgrade
|
| Shares Outstanding (Basic) | 561 | 582 | 600 | 457 | 450 | - | Upgrade
|
| Shares Outstanding (Diluted) | 561 | 582 | 600 | 457 | 450 | - | Upgrade
|
| Shares Change (YoY) | -6.41% | -3.01% | 31.18% | 1.64% | - | - | Upgrade
|
| EPS (Basic) | -0.05 | -0.06 | -0.02 | 0.06 | 0.07 | - | Upgrade
|
| EPS (Diluted) | -0.05 | -0.06 | -0.02 | 0.06 | 0.07 | - | Upgrade
|
| EPS Growth | - | - | - | -12.70% | - | - | Upgrade
|
| Free Cash Flow | -9.87 | -16.05 | 0.05 | 24.17 | 28.6 | 24.06 | Upgrade
|
| Free Cash Flow Per Share | -0.02 | -0.03 | - | 0.05 | 0.06 | - | Upgrade
|
| Dividend Per Share | - | - | 0.009 | - | - | - | Upgrade
|
| Gross Margin | 36.29% | 36.12% | 44.42% | 61.41% | 63.55% | 59.86% | Upgrade
|
| Operating Margin | -30.14% | -43.60% | -14.89% | 33.41% | 42.38% | 29.94% | Upgrade
|
| Profit Margin | -32.39% | -43.42% | -18.49% | 22.34% | 30.45% | 17.63% | Upgrade
|
| Free Cash Flow Margin | -11.69% | -21.49% | 0.07% | 18.97% | 27.16% | 28.46% | Upgrade
|
| EBITDA | -19.49 | -26.07 | -3.66 | 48.69 | 49.13 | 29.2 | Upgrade
|
| EBITDA Margin | -23.08% | -34.91% | -4.98% | 38.21% | 46.65% | 34.53% | Upgrade
|
| D&A For EBITDA | 5.96 | 6.49 | 7.29 | 6.13 | 4.49 | 3.89 | Upgrade
|
| EBIT | -25.45 | -32.56 | -10.95 | 42.56 | 44.64 | 25.31 | Upgrade
|
| EBIT Margin | -30.14% | -43.60% | -14.89% | 33.41% | 42.38% | 29.94% | Upgrade
|
| Effective Tax Rate | - | - | - | 28.93% | 26.31% | 38.08% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.